Skip to main content
Earnings Labs
Celularity Inc. logo

Celularity Inc. (CELU)

NASDAQ·Healthcare·Biotechnology

$0.78

+2.88%

Mkt Cap $37.34M

Analyst Ratings

No recent rating data.

Price Target (1 analysts)

$3.00

Range $3.00 – $3.00

Implied Upside

+283.6%

Consensus $3.00 vs current $0.78